POLARAMINE TABLETS dexchlorpheniramine maleate 2 mg blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

dexchlorpheniramine maleate, Quantity: 2 mg

Available from:

Bayer Australia Ltd

INN (International Name):

Dexchlorpheniramine maleate

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: pregelatinised maize starch; maize starch; lactose monohydrate; magnesium stearate

Administration route:

Oral

Units in package:

100 tablets, 50 tablets, 40 tablets, 20 tablets, 30 tablets

Prescription type:

(S3) Pharmacist Only Medicine

Therapeutic indications:

Polaramine is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. Polaramine may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and drug reactions, including serum sickness.

Product summary:

Visual Identification: off-white, round, flat beveled tablet with score on the one side, blank on the other side, free from foreign matter.; Container Type: Blister Pack; Container Material: Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2008-08-18